Fibrinogen, angina and coronary heart disease in a Chinese population

被引:19
|
作者
Lam, TH
Liu, LJ
Janus, ED
Lau, CP
Hedley, AJ
机构
[1] Univ Hong Kong, Dept Community Med, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Clin Biochem Unit, Hong Kong, Hong Kong, Peoples R China
[3] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China
关键词
coronary heart disease; fibrinogen; Chinese; Hong Kong;
D O I
10.1016/S0021-9150(99)00347-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although fibrinogen is an established risk factor of coronary heart disease (CHD), whether fibrinogen is associated with CHD in Chinese is not clear. This population-based cross-sectional study aimed to analyse this relationship in Hong Kong Chinese. Fibrinogen was measured by the Clauss method in 1348 men and 1385 women aged 25-74 years. Severity of CHD was defined as most serious if the subjects had medically diagnosed CHD, as less serious if they had angina only, and as normal if they had neither. The prevalence of angina and CHD was respectively 2.4% and 2.2% in men and 3.2% and 2.7% in women. In men the age-adjusted mean fibrinogen concentration was 2.47 (95% confidence interval (CI) 2.43-2.51) g/l in the normal group, 2.65 (95% CI 2.45-2.85) g/l in the angina group, and 2.78 (95% CI 2.56-3.00) g/l in the CHD cases (P < 0.01); in women it was respectively 2.61 (95% CI 2.59-2.63), 2.66 (95% CI 2.50-2.82), 2.90 (95% CI 2.72-3.08) g/l (P ( 0.01). The differences were significant after adjustment of other significant risk factors. We conclude that fibrinogen should be considered as a risk factor in Chinese. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:443 / 449
页数:7
相关论文
共 50 条
  • [41] Nonlinear Dynamics Analysis in Patients with Coronary Heart Disease in Chinese Analysis in coronary heart disease
    Wan, Heng
    Chihiro, Ohye
    [J]. ICCSSE 2009: PROCEEDINGS OF 2009 4TH INTERNATIONAL CONFERENCE ON COMPUTER SCIENCE & EDUCATION, 2009, : 801 - +
  • [42] Plasma fibrinogen in acute coronary syndrome and stable angina
    Gil, M
    Zarebinski, M
    Adamus, J
    [J]. CORONARY ARTERY DISEASE: PREVENTION TO INTERVENTION, 2000, : 535 - 538
  • [43] The experiences of Chinese patients with coronary heart disease
    Zhu, Lixia
    Ho, Shuk Ching
    Sit, Janet Wing Hung
    [J]. JOURNAL OF CLINICAL NURSING, 2012, 21 (3-4) : 476 - 484
  • [44] Angina and coronary disease
    Hannan, JH
    [J]. BRITISH MEDICAL JOURNAL, 1937, 1937 : 940 - 940
  • [45] TURNOVER OF I-131 FIBRINOGEN IN CORONARY HEART DISEASE AND LIPEMIA
    BLOMBACK, B
    CARLSON, LA
    [J]. JOURNAL OF ATHEROSCLEROSIS RESEARCH, 1963, 3 (03): : 242 - 244
  • [46] CORONARY HEART-DISEASE, FIBRINOGEN, AND PLASMA HEPARIN NEUTRALIZING ACTIVITY
    OBRIEN, JR
    ETHERINGTON, MD
    [J]. LANCET, 1981, 1 (8218): : 495 - 496
  • [47] Effects of Fibrinogen on Lipid Peroxidation in Patients with Coronary Heart Disease and in Vitro
    A. P. Savchenkova
    L. B. Dudnik
    I. L. Pogoretskaya
    N. P. Solov'eva
    M. A. Pokrovskaya
    A. V. Aseichev
    S. V. Drinitsyna
    O. A. Azizova
    Yu. M. Lopukhin
    [J]. Bulletin of Experimental Biology and Medicine, 2003, 135 : 29 - 33
  • [48] FIBRINOGEN - A LINK BETWEEN CHRONIC INFECTION AND CORONARY HEART-DISEASE
    PATEL, P
    CARRINGTON, D
    STRACHAN, DP
    LEATHAM, E
    GOGGIN, P
    NORTHFIELD, TC
    MENDALL, MA
    [J]. LANCET, 1994, 343 (8913): : 1634 - 1635
  • [49] Management of coronary heart disease: Stable angina, acute coronary syndrome, myocardial infarction
    Mehta, SB
    Wu, WC
    [J]. PRIMARY CARE, 2005, 32 (04): : 1057 - +
  • [50] Effects of fibrinogen on lipid peroxidation in patients with coronary heart disease and in vitro
    Savchenkova, AP
    Dudnik, LB
    Pogoretskaya, IL
    Solov'eva, NP
    Pokrovskaya, MA
    Aseichev, AV
    Drinitsyna, SV
    Azizova, OA
    Lopukhin, YM
    [J]. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2003, 135 (01) : 29 - 33